DashboardPortfolio'sControlelijstGemeenschapOntdekScreener
NOT FOR DISTRIBUTION

Hiscox Ltd

LSE:HSX Voorraadrapport

Marktkapitalisatie: UK£6.0b

  • Bedrijfsoverzicht
    • Waardering
    • Toekomstige groei
    • Prestaties in het verleden
    • Financiële gezondheid
    • Dividend
  • Beheer
  • Eigendom
  • Andere informatie
  • Aandelencommunity

Hiscox Toekomstige groei

Future criteriumcontroles 2/6

Hiscox zal naar verwachting groeien in winst en omzet met respectievelijk 5.9% en 12.4% per jaar. De winst per aandeel zal naar verwachting groeien met 7.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 15% zijn.

Belangrijke informatie

5.9%

Groei van de winst

7.93%

Groei van de winst per aandeel

Insurance winstgroei13.7%
Inkomstengroei12.4%
Toekomstig rendement op eigen vermogen15.00%
Dekking van analisten

Good

Laatst bijgewerkt11 Sep 2026

Recente toekomstige groei-updates

Recent updates

User avatar
Narratiefupdate • Sep 03

HSX: Higher Rating And Dividend Framework Will Support Bullish Repricing

Analysts have lifted their price target on Hiscox to £20.50 from £18.00, citing updated assumptions on fair value, revenue growth, profit margins and the future P/E multiple. What’s in the News for Hiscox Hiscox board declared an interim dividend of 16.8 ¢ per share for the six months to 30 June 2026, payable on 21 September 2026 to shareholders on the register as of 14 August 2026.
User avatar
Narratiefupdate • Aug 19

HSX: Rising P/E Expectations Will Likely Magnify Execution Risk

Analysts have raised their price target for Hiscox to £20.50 from £18.00, reflecting updated assumptions on fair value, discount rate, revenue growth, profit margins and future P/E expectations. Analyst Commentary The latest Street research on Hiscox sends a mixed message for investors.
User avatar
Narratiefupdate • Aug 05

HSX: Future Returns Will Balance Dividend Appeal With Execution And Rating Risks

The analyst price target for Hiscox has increased to £18.90 from £17.36. This change reflects updated assumptions on fair value, alongside recent target increases from several firms that cite supportive views on growth, margins and P/E valuation.
User avatar
Narratiefupdate • Jul 22

HSX: Higher Price Assumptions Will Likely Expose Elevated Execution Risk

The analyst price target for Hiscox has been raised from £1,800 to £2,050. Analysts cite adjusted fair value estimates, updated revenue growth and margin assumptions, and a series of higher Street targets as support for the new level.
User avatar
Narratiefupdate • Jul 08

HSX: Raised Price Expectations Will Likely Magnify Execution Risk

Analysts have nudged their fair value estimate for Hiscox higher to about £12 from roughly £11.44, reflecting recent upward revisions to Street price targets, including increases to £18.00 and £19.60, alongside a broader rebalancing of ratings. Analyst Commentary Recent commentary on Hiscox shows a mix of optimism and caution, with some bearish analysts flagging risks around how current pricing, execution and growth expectations line up with the latest fair value estimates.
User avatar
Narratiefupdate • Jun 24

HSX: Future Returns Will Weigh Dividend Income Against Execution And Rating Risks

Hiscox's analyst fair value estimate has edged up from £17.20 to £17.36, as analysts factor in recent price target moves around £1,800 to £1,960 and adjust their assumptions on future earnings multiples and profitability. Analyst Commentary Recent Street research on Hiscox points to an active period of reassessment, with several price target changes and at least one rating downgrade feeding into the current fair value estimate.
User avatar
Narratiefupdate • Jun 09

HSX: Future Returns Will Balance Dividend Appeal With Execution And Rating Risks

Hiscox’s analyst fair value estimate has been nudged up from £16.90 to £17.20 as analysts factor in updated price targets in the range of £1,800 to £1,960 and modest tweaks to growth and profitability assumptions. Analyst Commentary Recent research has clustered around higher price targets for Hiscox, with figures in the £18.00 to £19.60 range feeding into the latest fair value estimate.
User avatar
Narratiefupdate • May 26

HSX: Future Returns Will Balance Capital Returns With Execution And Rating Risks

Hiscox's analyst fair value estimate has shifted from £16.06 to £16.90, reflecting a series of higher Street price targets as analysts factor in updated assumptions on discount rates, revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent research is clustered around higher price targets for Hiscox, which feeds directly into the revised fair value estimate.
User avatar
Narratiefupdate • Apr 22

HSX: Future Returns Will Balance Capital Returns And Margin Execution Risks

Hiscox's updated fair value estimate edges to £16.06 from £16.35 as analysts lift price targets to £16.11 and £17.10, citing refined profit margin assumptions and P/E expectations, while keeping the discount rate and revenue growth broadly in line with prior views. Analyst Commentary Recent research has focused on refining how fairly Hiscox is priced, with price targets converging around the updated fair value estimate and modest changes to profit and P/E assumptions.
User avatar
Narratiefupdate • Apr 07

HSX: Future Returns Will Reflect Capital Returns And Earnings Delivery Risks

Analysts have nudged Hiscox's fair value estimate higher to £16.35 from £15.93, in line with recent Street price target lifts to £1,611 and £1,710 that reflect updated views on the stock's P/E assumptions and earnings potential. Analyst Commentary Recent Street research shows price targets clustered in the £16.11 to £17.10 range, which broadly supports the updated fair value estimate of £16.35.
User avatar
Narratiefupdate • Mar 24

HSX: Future Returns Will Reflect Capital Returns And Refined Earnings Expectations

Narrative update on Hiscox Hiscox's updated fair value estimate of £15.93 is broadly unchanged, and analysts have lifted price targets to £16.11 and £17.10, reflecting refreshed views on earnings potential and P/E assumptions. Analyst Commentary Recent price target updates cluster around the refreshed fair value estimate of £15.93, with targets of £16.11 and £17.10 signalling a range of views on how much execution and earnings strength are already reflected in the share price.
User avatar
Nieuw narratief • Mar 14

Retail Expansion And AI Investments Will Reshape This Specialty Insurer’s Long Term Earnings Profile

Catalysts About Hiscox Hiscox is an international insurer focused on specialty, retail and reinsurance lines for consumers, small businesses and larger corporate clients. What are the underlying business or industry changes driving this perspective?
User avatar
Narratiefupdate • Mar 08

HSX: Future Returns Will Reflect Capital Returns And Refined Margin Expectations

Analysts have lifted their price targets for Hiscox, with updated modelling nudging fair value from £15.17 to £15.95. This is supported by Street research that cites higher targets of £16.11 and £17.10, along with refined assumptions on revenue growth, profit margin and future P/E.
User avatar
Nieuw narratief • Feb 26

AI Reliance And Execution Risks Will Pressure Margins And Challenge Optimistic Expectations

Catalysts About Hiscox Hiscox is an international insurer and reinsurer focused on retail, London market and reinsurance lines, with a growing digital small commercial platform. What are the underlying business or industry changes driving this perspective?
User avatar
Narratiefupdate • Feb 21

HSX: Future Returns Will Reflect Buyback Activity And Margin-Focused Upside Potential

Analysts have nudged their Hiscox price target higher from £14.89 to £15.17, citing updated assumptions around slightly lower revenue growth expectations, balanced by firmer profit margin forecasts and a modestly higher future P/E multiple. What's in the News Hiscox has repurchased 12,568,259 shares between July 1, 2025 and December 19, 2025, for a total of US$222.5 million, representing 3.74% of the company.
User avatar
Narratiefupdate • Feb 06

HSX: Future Returns Will Reflect Under-Earning Risks And Buyback-Supported Upside Potential

Analysts have cut their price target on Hiscox from £15.00 to £10.68, citing views that the company is currently under earning with return on equity trailing sector peers. This feeds into updated fair value, discount rate, growth and P/E assumptions.
User avatar
Narratiefupdate • Jan 21

HSX: Future Returns Will Balance Under-Earning Concerns With Buyback-Driven Confidence

The analyst price target for Hiscox has been revised lower to £10.69 from £15.00 as analysts factor in views that the business is currently under-earning, with return on equity trailing peers, despite differing opinions reflected in recent target changes around £15.00. Analyst Commentary Bullish Takeaways Bullish analysts see scope for upside execution, reflected in a higher £15.00 price target, suggesting confidence that the current earnings profile may not fully reflect the business potential.
User avatar
Narratiefupdate • Nov 07

HSX: Strong First Half Performance Will Drive Renewed Confidence Ahead

The analyst consensus price target for Hiscox has increased from £14.88 to £15.21 per share. This reflects analysts' improved outlook following strong results and a narrowing valuation gap.
Analyse-artikel • Nov 03

Insufficient Growth At Hiscox Ltd (LON:HSX) Hampers Share Price

With a price-to-earnings (or "P/E") ratio of 10.1x Hiscox Ltd ( LON:HSX ) may be sending bullish signals at the moment...
User avatar
Narratiefupdate • Oct 24

Capital Returns And Dividend Increases Will Support Performance Amid Market Risks

Analysts have modestly raised their fair value estimate for Hiscox from £14.82 to £14.88. They cite narrowing valuation gaps and an improved capital return outlook, as reflected in recent price target upgrades by the Street.
User avatar
Narratiefupdate • Oct 10

New Bermuda Tax And Catastrophe Risks Will Reduce Future Profitability

Narrative Update on Hiscox The analyst consensus price target for Hiscox has increased modestly, rising from £14.59 to £14.82. Analysts cite stronger-than-expected earnings forecasts and robust sector performance to support their raised valuations.
User avatar
Narratiefupdate • Sep 03

New Bermuda Tax And Catastrophe Risks Will Reduce Future Profitability

Analysts have modestly raised Hiscox’s price target to £14.64, citing increased confidence in sustainable earnings growth, improved underwriting discipline, and the success of its retail-focused strategy despite a challenging market environment. Analyst Commentary Bullish analysts highlight Hiscox's new retail strategy as a key differentiator, particularly as the large ticket reinsurance and commercial market environment is expected to soften.
User avatar
Nieuw narratief • Mar 02

New Bermuda Tax And Catastrophe Risks Will Reduce Future Profitability

High capital returns constrain future expansion and operational investment, potentially affecting net margins and earnings.

Winst- en omzetgroeiprognoses

LSE:HSX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20285,9287316737775
12/31/20275,5625845916895
12/31/20265,3595465906943
6/30/20264,116641696736N/A
3/31/20264,070623361404N/A
12/31/20254,0256042673N/A
9/30/20253,9766002066N/A
6/30/20253,9275951359N/A
3/31/20253,8686114487N/A
12/31/20243,80862775114N/A
9/30/20243,794674202241N/A
6/30/20243,780721328367N/A
3/31/20243,740716258300N/A
12/31/20233,700712188232N/A
9/30/20233,483591120177N/A
6/30/20233,26747052121N/A
3/31/20233,121362171247N/A
12/31/20222,975254291373N/A
9/30/20222,921179168245N/A
6/30/20222,86610446116N/A
3/31/20222,944147266N/A
12/31/20213,023190-4217N/A
9/30/20213,04783-53-7N/A
6/30/20213,071-24-64-30N/A
3/31/20213,035-159-121-73N/A
12/31/20203,000-294-178-117N/A
9/30/20202,930-270-4835N/A
6/30/20202,860-24783187N/A
3/31/20202,886-99N/A113N/A
12/31/20192,91249N/A40N/A
9/30/20192,86882N/A-111N/A
6/30/20192,824115N/A-261N/A
3/31/20192,741116N/A19N/A
12/31/20182,659118N/A300N/A
9/30/20182,64588N/A344N/A
6/30/20182,63259N/A388N/A
3/31/20182,60446N/A241N/A
12/31/20172,57534N/A95N/A
9/30/20172,653177N/A159N/A
6/30/20172,508304N/A218N/A
3/31/20172,348360N/A145N/A
12/31/20162,198415N/A70N/A
9/30/20162,175399N/A-89N/A
6/30/20162,090370N/A-257N/A
3/31/20162,203351N/A-88N/A
12/31/20152,194310N/A105N/A
9/30/20152,224330N/A482N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei HSX ( 5.9% per jaar) ligt boven de spaarquote ( 3.6% ).

Winst versus markt: De winst van HSX ( 5.9% per jaar) zal naar verwachting langzamer groeien dan de markt UK ( 11.2% per jaar).

Hoge groeiwinsten: De winst van HSX zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van HSX ( 12.4% per jaar) zal naar verwachting sneller groeien dan de markt UK ( 3.7% per jaar).

Hoge groei-inkomsten: De omzet van HSX ( 12.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen HSX zal naar verwachting over 3 jaar laag zijn ( 15 %).


Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/16 07:57
Aandelenkoers aan het einde van de dag2026/09/16 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
  • SEC-formulier 10-K
  • SEC-formulier 10-Q
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
  • Onderzoeksrapporten van analisten
  • Blue Matrix
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
  • ICE Marktgegevens
  • SEC-formulier S-1
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
  • SEC-formulier 4
  • SEC-formulier 13D
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
  • SEC-formulier 10-K
  • SEC-formulier DEF 14A
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen
  • SEC-formulier 8-K

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Hiscox Ltd wordt gevolgd door 26 analisten. 8 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Ivan BokhmatBarclays
Michael ChristodoulouBerenberg
Thomas SeidlBernstein

Neem overal betere beleggingsbeslissingen

Scan om te downloaden
Open App StoreGoogle Play openen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Gegevensbronnen bekijken
Markten
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Beleggingsideeën
  • Ondergewaardeerde bedrijven
  • Dividendkrachtpatsers
  • Kopen met voorkennis
  • Kernenergie
  • Autonome voertuigen
  • Kunstmatige intelligentie
  • Crypto en blockchain
  • Cyberbeveiliging
  • Meer ideeën
Voorraad Gemeenschappen
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Functies en gereedschappen
  • Portfolio Volger
  • Aandelen screener & waarschuwingen
  • Diverse en eerlijke waarden
  • Dividend berekenen
Nieuws & Ontdekkingen
  • Laatste voorraadnieuws
  • Globale markt Inzichten
  • De Foxhole
  • Beleggingsideeën
  • Community nominale waarden
  • Nieuw
Simply Wall St
  • Plannen en prijzen
  • Adverteren
  • Over ons
  • Neem contact met ons op
  • Carrière
  • Helpcentrum
  • Leren beleggen in aandelen
  • Affiliate programma
  • Bedrijf & Onderneming
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Algemene voorwaarden
  • Privacybeleid
  • AI-voorwaarden
  • Gids voor financiële diensten